Uso de la escala CHADS 2 como predictor de riesgo de mortalidad en pacientes hipertensos. El estudio FAPRES / Use of the CHADS 2 score as a predictor of the risk of mortality in hypertensive patients. The FAPRES study
Med. clín (Ed. impr.)
; 146(11): 478-483, jun. 2016. tab, graf
Article
in Spanish
| IBECS
| ID: ibc-152127
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Fundamentos y objetivo:
El objetivo del estudio es analizar la escala CHADS2 como marcador de riesgo de mortalidad en pacientes hipertensos, independientemente de la presencia o no de fibrilación auricular.Métodos:
Se incluyó a 1.003 pacientes hipertensos ≥ 65 años, recogiendo factores de riesgo y puntuación CHADS2. Se realizó un seguimiento clínico de la mortalidad.Resultados:
La media de edad de la población fue 72,8 ± 5,8 años; el 47,5% eran varones. Durante el seguimiento hubo 41 muertes, 20 de origen cardiovascular. Los pacientes con mayor CHADS2 tuvieron una mayor mortalidad 1,5% en CHADS2 = 1; 4,7% en CHADS2 = 2; 9,1% en CHADS2 = 3, y 7,8% en CHADS2 ≥ 4.Conclusiones:
La puntuación CHADS2 puede ser un instrumento clínico de sencilla aplicación para identificar pacientes hipertensos con alto riesgo de mortalidad (AU)ABSTRACT
Foundations and aim:
The aim of this study is to analyze the CHADS2 score as a marker of the risk of mortality in hypertensive patients, with and without the presence of atrial fibrillation.Methods:
We included 1,003 hypertensive patients ≥ 65 years. Risk factors, and CHADS2 score were recorded among other factors, as well as clinical follow-up of number and type of deaths.Results:
Mean age was 72.8 ± 5.8 years, and 47.5% were men. During follow-up there were 41 deaths, 20 were of cardiovascular origin. Patients with higher CHADS2 had a higher mortality 1.5% CHADS2 = 1; 4.7% in CHADS2 = 2; 9.1% in CHADS2 = 3, and 7.8% in CHADS2 ≥ 4.Conclusions:
The CHADS2 score can be a clinical instrument of easy application to identify hypertensive patients with a high risk of mortality (AU)
Search on Google
Collection:
National databases
/
Spain
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
/
Arterial Hypertension
/
Cardiovascular Disease
/
Cerebrovascular Disease
Database:
IBECS
Main subject:
Preventive Health Services
/
Atrial Fibrillation
/
Blood Coagulation
/
Biomarkers
/
Risk Factors
/
Mortality
/
Hypertension
Type of study:
Controlled clinical trial
/
Diagnostic study
/
Etiology study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
Spanish
Journal:
Med. clín (Ed. impr.)
Year:
2016
Document type:
Article
Institution/Affiliation country:
Hospital General Universitario de Elche/España
/
Hospital General de Valenica/España
/
Universidad Jaume I/España